Evidence map›Paper›PMID 36414333›Full record

ArticleLupus science & medicine2022

Intermuscular adipose tissue in patients with systemic lupus erythematosus.

Jorge Luis Gamboa, Daniel Carranza-León, Rachelle Crescenzi, Michael Pridmore, Dungeng Peng, Adriana Marton, Annette Oeser, Cecilia P Chung, Jens Titze, Charles Michael Stein and 1 more

Open access · goldAbstract read
In one paragraph

Article in Lupus science & medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Intermuscular Adipose Tissue in CKD: A Window into Muscle Quality and Health?Clinical journal of the American Society of Nephrology : CJASN · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Jorge Luis GamboaDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA jorge.gamboa@vanderbilt.edu.ORCID 0000-0002-4204-7670
Daniel Carranza-LeónDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Rachelle CrescenziDepartment of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Michael PridmoreDepartment of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Dungeng PengDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Adriana MartonProgram in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore.
Annette OeserDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Cecilia P ChungDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Jens TitzeProgram in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore.
Charles Michael SteinDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Michelle OrmsethDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Vanderbilt University Medical Center · USDuke-NUS Medical School · SGUnited States Department of Veterans Affairs · USVanderbilt University · US

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
Postdoctoral Training in Biomedical MRI and MRST32EB001628 · NIBIB · VANDERBILT UNIVERSITY MEDICAL CENTER · PI John C Gore · 2003 to 2026
$7.0M
Salt, Blood Pressure, and InflammationR01HL140145 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STEIN, CHARLES M. · 2018 to 2021
$2.3M
Console upgrades for biological NMR spectrometersS10RR025677 · NCRR · VANDERBILT UNIVERSITY · PI SANDERS, CHARLES R · 2009 to 2009
$460k
NCATS NIH HHS UL1 TR002243NCRR NIH HHS S10 RR025677NHLBI NIH HHS R01 HL140145NIBIB NIH HHS T32 EB001628
6 · The paper itself

Abstract

objectivePatients with SLE frequently have debilitating fatigue and reduced physical activity. Intermuscular adipose tissue (IMAT) accumulation is associated with reduced physical exercise capacity. We hypothesised that IMAT is increased in patients with SLE and associated with increased fatigue, reduced physical activity and increased inflammation.

methodsIn a cross-sectional study, 23 patients with SLE and 28 control participants were evaluated. IMAT was measured in the calf muscles using sequential

resultsIMAT accumulation (percentage of IMAT area to muscle area) was significantly higher in SLE versus control participants (7.92%, 4.51%-13.39% vs 2.65%, 1.15%-4.61%, median, IQR, p<0.001) and remained significant after adjustment for age, sex, race and body mass index (p<0.001). In patients with SLE, IMAT accumulation did not differ significantly among corticosteroid users and non-users (p=0.48). In the study cohort (patients and controls), IMAT was positively correlated with self-reported fatigue score (rho=0.52, p<0.001) and inversely correlated with self-reported walking distance (rho=-0.60, p<0.001). Several markers of inflammation were associated with IMAT accumulation in patients with SLE, and gene ontology analysis showed significant enrichment for pathways associated with macrophage migration and activation in relation to IMAT.

conclusionPatients with SLE have greater IMAT accumulation than controls in the calf muscles. Increased IMAT is associated with greater fatigue and lower physical activity. Future studies should evaluate the effectiveness of interventions that improve muscle quality to alleviate fatigue in patients with SLE.

Indexed as

Lupus Erythematosus, SystemicProteomicsAdipose TissueCross-Sectional StudiesFatigueHumansInflammationinflammationlipidssystemic lupus erythematosus

Identifiers

PMID36414333
PMCPMC9684966
OpenAlexW4309592863

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.